+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Indolent Lymphoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Indolent Lymphoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Kaposi's Sarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Kaposi's Sarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Liposarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Liposarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Colorectal Neoplasm - Epidemiology Forecast to 2032 - Product Thumbnail Image

Colorectal Neoplasm - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Cancer Therapy Related Diarrhea - Epidemiology Forecast - 2032 - Product Thumbnail Image

Cancer Therapy Related Diarrhea - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
CAR-T - Epidemiology Forecast - 2032 - Product Thumbnail Image

CAR-T - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
CD19/CD20 Bi-specific CAR-T - Epidemiology Forecast - 2032 - Product Thumbnail Image

CD19/CD20 Bi-specific CAR-T - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Oncolytic Adenovirus - Epidemiology Forecast - 2032 - Product Thumbnail Image

Oncolytic Adenovirus - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
From
Chronic Myelogenous Leukemia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Myelogenous Leukemia - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Clear cell sarcoma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Clear cell sarcoma - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pheochromocytoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pheochromocytoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
DDR defective tumors - Epidemiology Forecast - 2032 - Product Thumbnail Image

DDR defective tumors - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Desmoid Tumors - Epidemiology Forecast - 2032 - Product Thumbnail Image

Desmoid Tumors - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more